Published in Vaccine Weekly, April 17th, 1995
Because the meningococcal transferrin receptor was shown to elicit bactericidal and protective antibodies in laboratory animals, researcher Ling Lissolo et al. undertook a study of the protective role of each of the polypeptides within the Tbp1-Tbp2 complex.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.